Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Has announcements × Endometrial Neoplasms × lenvatinib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasms 2 Carcinoma, Hepatocellular 2 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Endometrial Neoplasms 1 Carcinoma, Renal Cell 1

Interventions

pembrolizumab 3 Paclitaxel 3 Carboplatin 2 sacituzumab govitecan 1 olaparib 1 lenvatinib 1 durvalumab 1 Taxes 1 Doxorubicin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03517449 2025-06-15

MK-3475-775

Eisai Inc.

Phase 3 Completed

827 enrolled 18 charts 1 FDA

Parkinson Disease 4, Autosomal Dominant Lewy Body, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡